Month: April 2019

Month: April 2019

Ryah Medtech Inc. Files Application with Health Canada for RYAH Medicinal CBD Cartridges

NEW YORK, April 25, 2019 (GLOBE NEWSWIRE) — Ryah Medtech Inc. (“RYAH” or the “Company”) announced today that it has filed a Medical Device Establishment License application with Health Canada for its commercial grade cannabinoid cartridges. These cartridges are used with RYAH’s ground-breaking dose-measuring medicinal vaporizer for CBD and other cannabinoids or dry herbs.

Snipp Interactive Reports Financial Results for Q4 2018 and Fiscal 2018

TORONTO, April 30, 2019 (GLOBE NEWSWIRE) — Snipp Interactive Inc. (“Snipp” or the “Company”) (TSX-V: SPN; OTCPK: SNIPF), a global provider of digital marketing promotions, rebates and loyalty solutions, is pleased to announce its financial results for Q4 2018 and the year ended December 31, 2018 (“Fiscal 2018”). All results are reported under International Financial Reporting Standards (“IFRS”) and in US dollars. A copy of the complete audited financial statements and management’s discussion and analysis are available on SEDAR (

Cannara Biotech Reports Q2 2019 Results

VANCOUVER, April 29, 2019 /CNW/ – Cannara Biotech (“Cannara” or the “Company”) (CSE: LOVE) (FRA: 8CB), an emerging vertically integrated cannabis company focused on the cultivation and sale of dried cannabis and cannabis-infused products to the Canadian and international markets, today announced financial results for the three month and six month periods ended February 28, 2019.

High Tide Announces Licence from AGCO to Open Canna Cabana-Branded Cannabis Retail Store in Toronto

CALGARY, April 29, 2019 /CNW/ – High Tide Inc. (“High Tide” or the “Company”) (CSE:HITI) (OTCQB:HITIF) (FRA:2LY), an Alberta-based, retail-focused cannabis corporation enhanced by the manufacturing and wholesale distribution of smoking accessories and cannabis lifestyle products, announced that on Friday, April 26, 2019 the Alcohol and Gaming Commission of Ontario (“AGCO”) approved and issued a Retail Operator Licence (the “Licence”) to High Tide’s counterparty Dana Michele Kendal (the “Winner”) for the Canna Cabana Toronto store (the “Toronto Store”). A Retail Store Authorization will also be required to be issued by the AGCO for the Winner to finalize the set-up of the Toronto Store. The Winner is aiming to open Canna Cabana Toronto on or before June 1, 2019.

FSD Pharma Announces Share Exchange Transaction with Aura Health

TORONTO, April 24, 2019 /CNW/ – FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) announced today that it has entered into a share exchange transaction with Aura Health Inc. (“Aura”). Pursuant to the agreement, FSD acquired 13,562,386 Aura shares valued at $3 million issued from treasury in exchange for 13,181,019 FSD shares issued from treasury valued at $3 million. Aura Health is a Toronto-based cannabis company building an international network of vertically integrated businesses in the medical cannabis industry.

Canntab Advances its Revenue Model with Recent Sales License Approval for FSD Pharma from Health Canada

TORONTO, April 23, 2019 /PRNewswire/ – Canntab Therapeutics Limited (CSE: PILL) (OTCQB: CTABF) (FRA: TBF1) (the “Company” or “Canntab”) is pleased to announce that by virtue of FSD Pharma Inc. (“FSD”), with whom Canntab has entered into a collaboration and profit sharing agreement, being granted a “sale for medical purposes” licence by Health Canada pursuant to the Cannabis Act and Cannabis Regulations (the “FSD Licence”), Canntab is close to being in a position to sell its products and generate revenue. The FSD Licence allows Canntab to produce samples of capsules containing CBD and/or THC, which, if approved by Health Canada, will enable Canntab to launch production and sales out of its manufacturing facility located in Room 6 of FSD’s Health Canada approved

FSD Pharma to Acquire Prismic Pharmaceuticals

TORONTO, April 23, 2019 /CNW/ – FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) (“FSD Pharma” or the “Company”) and Prismic Pharmaceuticals Inc. (“Prismic”), a US-based specialty R&D pharmaceutical company, announced today that they have entered into a securities exchange agreement dated April 22, 2019 (the “Agreement”) pursuant to which FSD Pharma has agreed to acquire all of the outstanding securities of Prismic (the “Transaction”). Prismic is developing novel non-addictive prescription drugs with unique safety profiles with the goal of addressing the opioid crisis based on formulations utilizing micro-palmitoylethanolamide’s (“PEA”) “entourage” effect on certain drugs impacting the endocannabinoid system.

High Tide Receives $8.4 Million from First Tranche Closing of Convertible Debenture Offering

CALGARY, April 22, 2019 /CNW/ – High Tide Inc. (“High Tide” or the “Company”) (CSE:HITI) (OTCQB:HTDEF) (FRA:2LY), an Alberta-based, retail-focused cannabis corporation enhanced by the manufacturing and wholesale distribution of smoking accessories and cannabis lifestyle products, today announced that it has closed the first tranche of the sale of unsecured convertible debentures (the “Debentures”) of the Company under the non-brokered private placement (the “Offering”) previously announced on April 10, 2019, with gross proceeds of $8,360,000 to date. High Tide intends to close a second and final tranche of the Offering for aggregate gross proceeds of up to $15,000,000, which has been increased from the original amount of $10,000,000 due to strong investor demand.

World Class Announces Listing on Frankfurt Stock Exchange

TORONTO, April 17, 2019 (GLOBE NEWSWIRE) — World Class Extractions Inc. (CSE: PUMP) (the “Company” or “World Class”) is pleased to announce that its common shares are now listed on the Frankfurt Stock Exchange and are trading under the ticker symbol “WCF” and “WKN: A2PF9C”. The Company’s common shares continue to be listed on the Canadian Stock Exchange under the ticker symbol “PUMP”.